Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm

被引:29
作者
Randhawa, Mohammad A. [1 ]
Gondal, Mohammed A. [2 ]
Al-Zahrani, Al-Hosain J. [3 ]
Rashid, Siddique G. [2 ]
Ali, Ashraf [4 ]
机构
[1] Univ Dammam, Ctr Res & Consultat Studies, Dammam, Saudi Arabia
[2] Ctr Excellence Nanotechnol CENT, Laser Res Grp, Dhahran, Saudi Arabia
[3] King Saud Univ, Dept Appl Med, Riyadh, Saudi Arabia
[4] Ctr Refining & Petrochem, Dhahran, Saudi Arabia
来源
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING | 2015年 / 50卷 / 02期
关键词
Candida albicans yeasts and biofilm; thymoquinone; nanodrugs; ketoconazole; Amphotericin-B; PROSTHETIC VALVE ENDOCARDITIS; NIGELLA-SATIVA; RESISTANCE; NANOPARTICLES; PRINCIPLE; MATRIX;
D O I
10.1080/10934529.2015.975042
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
In the current study, nano-particulated drugs-Amphotericin-B, Ketoconazole and Thymoquinone (an active ingredient of Nigella sativa)-were prepared using the ball milling technique, and their particle sizes were examined by transmission electron microscopy (TEM) and using a particle size analyzer. The grain sizes of the prepared compounds were found in between 5 to 20nm, and exhibited quasi-spherical morphology. The antifungal activity of each nano-particulated drug was investigated in vitro against Candida albicans yeasts and Candida biofilm, and compared with their micro-structured conventional forms. Nano-sized drugs were found to be two to four times more effective in disinfecting both the Candida yeasts and Candida biofilm. The study is a first of its kind as nano-forms of drugs have not been studied against Candida and Candida biofilm before. Further investigations are required for the determination of the clinical significance of the nano-formulation of antifungal substances.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 38 条
[1]   Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone [J].
Aljabre, SHM ;
Randhawa, MA ;
Akhtar, N ;
Alakloby, OM ;
Alqurashi, AM ;
Aldossary, A .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 101 (1-3) :116-119
[2]   ESTABLISHMENT OF AGING BIOFILMS - POSSIBLE MECHANISM OF BACTERIAL-RESISTANCE TO ANTIMICROBIAL THERAPY [J].
ANWAR, H ;
STRAP, JL ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1347-1351
[3]   Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) :397-403
[4]  
Baillie GS, 1999, METHOD ENZYMOL, V310, P644
[5]  
Cardinal E, 1996, ORTHOPEDICS, V19, P247
[6]   Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation [J].
Chaieb, Kamel ;
Kouidhi, Bochra ;
Jrah, Hanene ;
Mahdouani, Kacem ;
Bakhrouf, Amina .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
[7]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[8]   Intravascular catheter-associated infections [J].
Crump, JA ;
Collignon, PJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (01) :1-8
[9]   The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis [J].
Gelperina, S ;
Kisich, K ;
Iseman, MD ;
Heifets, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) :1487-1490
[10]   Successful treatment of fungal prosthetic valve endocarditis: Case report and review [J].
Gilbert, HM ;
Peters, ED ;
Lang, SJ ;
Hartman, BJ .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) :348-354